AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 16, 2026

Daily Signals

2761 companies scored · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run
Companies scored 2761 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.72% Total · 30D
Long–short spread +2.72% Strong Buy minus Strong Sell, mean
Median IC 0.17 Spearman · 30D
Rating changes ▲ 218 ▼ 403 vs the previous run
Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

2761 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
2501 CATXPerspective Therapeutics, Inc. Life Sciences 0.08 $248M Unlock rating and forecasts
2502 EFSIEAGLE FINANCIAL SERVICES INC Finance 0.35 $248M Unlock rating and forecasts
2503 NPWRNet Power Inc. Manufacturing -0.05 $247M Unlock rating and forecasts
2504 STRTSTRATTEC SECURITY CORP Manufacturing 0.10 $247M Neutral +0.60% +2.17% ·
2505 EVIEVI INDUSTRIES, INC. Trade & Services 0.11 $245M Unlock rating and forecasts
2506 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.08 $244M Unlock rating and forecasts
2507 HQIHireQuest, Inc. Trade & Services 0.20 $243M Unlock rating and forecasts
2508 JACKJACK IN THE BOX INC Trade & Services 0.21 $243M Unlock rating and forecasts
2509 PEBKPEOPLES BANCORP OF NORTH CAROLINA INC Finance 0.16 $241M Neutral +0.57% +1.86% ▲ 1
2510 GRRRGorilla Technology Group Inc. Technology 0.03 $241M Unlock rating and forecasts
2511 REFIChicago Atlantic Real Estate Finance, Inc. Real Estate & Construction 0.03 $241M Unlock rating and forecasts
2512 TLSITriSalus Life Sciences, Inc. Industrial Applications and Services 0.14 $240M Unlock rating and forecasts
2513 ABEOABEONA THERAPEUTICS INC. Life Sciences -0.01 $240M Unlock rating and forecasts
2514 PPIHPerma-Pipe International Holdings, Inc. Technology 0.07 $240M Neutral +0.71% +2.53% ·
2515 CABACabaletta Bio, Inc. Life Sciences -0.02 $239M Unlock rating and forecasts
2516 UTMDUTAH MEDICAL PRODUCTS INC Industrial Applications and Services 0.21 $239M Unlock rating and forecasts
2517 AIVAPARTMENT INVESTMENT & MANAGEMENT CO Real Estate & Construction 0.44 $238M Unlock rating and forecasts
2518 AMRNAMARIN CORP PLC\UK Life Sciences 0.13 $238M Neutral +0.85% +2.46% ·
2519 IMMRIMMERSION CORP Technology 0.20 $237M Neutral +0.69% +2.44% ·
2520 SABSSAB Biotherapeutics, Inc. Life Sciences 0.30 $236M Neutral +0.87% +2.76% ·
2521 IMRXImmuneering Corp Life Sciences 0.30 $235M Unlock rating and forecasts
2522 KGEIKolibri Global Energy Inc. Energy & Transportation 0.27 $235M Unlock rating and forecasts
2523 CMTVCOMMUNITY BANCORP /VT Finance 0.07 $234M Neutral +0.98% +2.57% ·
2524 GWRSGlobal Water Resources, Inc. Energy & Transportation -0.09 $233M Neutral +0.52% +1.83% ·
2525 NEGGNewegg Commerce, Inc. Trade & Services -0.21 $233M Unlock rating and forecasts
2526 AENTALLIANCE ENTERTAINMENT HOLDING CORP Trade & Services 0.40 $231M Unlock rating and forecasts
2527 FATEFATE THERAPEUTICS INC Life Sciences 0.05 $231M Unlock rating and forecasts
2528 PROFProfound Medical Corp. Industrial Applications and Services 0.13 $231M Unlock rating and forecasts
2529 EXFYExpensify, Inc. Technology 0.34 $230M Unlock rating and forecasts
2530 SIGASIGA TECHNOLOGIES INC Life Sciences 0.35 $229M Neutral +0.94% +2.73% ·
2531 XPOFXponential Fitness, Inc. Trade & Services 0.30 $228M Unlock rating and forecasts
2532 SMRTSmartRent, Inc. Technology -0.05 $228M Unlock rating and forecasts
2533 AOUTAmerican Outdoor Brands, Inc. Manufacturing 0.01 $228M Neutral +1.08% +3.23% ▼ 2
2534 FORRFORRESTER RESEARCH, INC. Trade & Services 0.32 $227M Neutral +0.88% +2.57% ·
2535 ASLEAerSale Corp Trade & Services 0.19 $227M Neutral +0.61% +2.17% ·
2536 ZSQRZ Squared Inc. Finance or Crypto Assets 0.21 $227M Unlock rating and forecasts
2537 INBKFirst Internet Bancorp Finance 0.12 $227M Unlock rating and forecasts
2538 LXEOLexeo Therapeutics, Inc. Life Sciences -0.12 $226M Unlock rating and forecasts
2539 XPERAdeia Inc. Technology -0.05 $225M Unlock rating and forecasts
2540 GLSIGreenwich LifeSciences, Inc. Life Sciences 0.12 $225M Unlock rating and forecasts
2541 SPOKSpok Holdings, Inc Technology 0.20 $224M Neutral +0.54% +1.80% ·
2542 ASYSAMTECH SYSTEMS INC Technology 0.12 $224M Unlock rating and forecasts
2543 MBIMBIA INC Finance 0.19 $224M Unlock rating and forecasts
2544 SVCOSilvaco Group, Inc. Technology 0.43 $223M Unlock rating and forecasts
2545 ONITONITY GROUP INC. Finance 0.13 $223M Unlock rating and forecasts
2546 NATRNATURES SUNSHINE PRODUCTS INC Life Sciences 0.41 $222M Unlock rating and forecasts
2547 UXINUxin Ltd Trade & Services 0.14 $222M Unlock rating and forecasts
2548 BIOABioAge Labs, Inc. Life Sciences 0.32 $222M Unlock rating and forecasts
2549 OPBKOP Bancorp Finance -0.01 $222M Unlock rating and forecasts
2550 KROSKeros Therapeutics, Inc. Life Sciences 0.26 $220M Neutral +0.92% +2.87% ·
2501–2550 of 2761 Previous Next
Since the previous run

Rating changes

▲ 218▼ 403
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.